These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2537557)

  • 1. Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans.
    Nussberger J; Juillerat L; Perret F; Waeber B; Bellet M; Brunner J; Ménard J
    Am Heart J; 1989 Mar; 117(3):717-22. PubMed ID: 2537557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
    Mooser V; Nussberger J; Juillerat L; Burnier M; Waeber B; Bidiville J; Pauly N; Brunner HR
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):276-82. PubMed ID: 1689424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of enalapril.
    Abrams WB; Davies RO; Gomez HJ
    J Hypertens Suppl; 1984 Dec; 2(2):S31-6. PubMed ID: 6100874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
    Hollenberg NK; Fisher ND; Price DA; Williams GH
    Am J Hypertens; 2000 May; 13(5 Pt 1):498-503. PubMed ID: 10826400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and renin inhibition.
    Nussberger J; Waeber B; Brunner HR
    J Hypertens Suppl; 1989 Apr; 7(2):S75-9. PubMed ID: 2666618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition.
    Nussberger J; Waeber B; Brunner HR
    Am J Hypertens; 1989 Apr; 2(4):286-93. PubMed ID: 2650711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril.
    Hoshida S; Nishida M; Yamashita N; Igarashi J; Aoki K; Hori M; Kuzuya T; Tada M
    Atherosclerosis; 1997 Apr; 130(1-2):53-9. PubMed ID: 9126648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiotensin-converting enzyme with libenzapril in normotensive males.
    Morgan JM; Piraino AJ; Saris SD; Graham CS; Hirschhorn WL; Kochak GM; Choi RL
    J Clin Pharmacol; 1994 Dec; 34(12):1177-82. PubMed ID: 7738213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of angiotensin II generation during converting enzyme inhibition.
    Juillerat L; Nussberger J; Ménard J; Mooser V; Christen Y; Waeber B; Graf P; Brunner HR
    Hypertension; 1990 Nov; 16(5):564-72. PubMed ID: 2172161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of converting enzyme activity by antibody-trapping of generated angiotensin II. Comparison with two other methods.
    Nussberger J; Brunner D; Keller I; Brunner HR
    Am J Hypertens; 1992 Jun; 5(6 Pt 1):393-8. PubMed ID: 1326287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
    Kawamura M; Imanishi M; Matsushima Y; Akabane S; Kuramochi M; Ito K; Omae T
    Jpn J Pharmacol; 1990 Oct; 54(2):143-9. PubMed ID: 1963909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment.
    Kohzuki M; Johnston CI; Chai SY; Jackson B; Perich R; Paxton D; Mendelsohn FA
    J Hypertens; 1991 Jul; 9(7):579-87. PubMed ID: 1653792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of different clinical and biochemical correlates to assess angiotensin converting enzyme inhibition.
    Delacrétaz E; Nussberger J; Püchler K; Wood AJ; Robinson PR; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):479-85. PubMed ID: 7528305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.